Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: The ARISTOTLE programme

Addiction

Volumn 110, Issue 9, 2015, Pages 1453-1467

  Hatzakis, Angelos ^a   Sypsa, Vana ^a   Paraskevis, Dimitrios ^a   Nikolopoulos, Georgios ^b   Tsiara, Chrissa ^c   Micha, Katerina ^d   Panopoulos, Anastasios ^d   Malliori, Meni ^a   Psichogiou, Mina ^a   Pharris, Anastasia ^e   Wiessing, Lucas ^f   van de Laar, Marita ^g   Donoghoe, Martin ^h   Heckathorn, Douglas D ⁱ   Friedman, Samuel R ^j   Des Jarlais, Don C ^k  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b IAS NIDA Hellenic Center for Diseases Prevention and Control   (Greece)

^c Hellenic Centre for Disease Control and Prevention   (Greece)

^d Hellenic Drug Organization (EOF)   (Greece)

^e EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^f EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION   (Portugal)

^g Independent public health consultant   (Netherlands)

^h WORLD HEALTH ORGANIZATION   (Switzerland)

ⁱ Cornell University ^*  (United States)

^j NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^k BETH ISRAEL MEDICAL CENTER   (United States)

more..

Author keywords

HIV outbreak; Intervention; Prevalence; PWIDs; Respondent driven sampling; Risk factors

Indexed keywords

ADOLESCENT; ADULT; AGED; COMORBIDITY; EPIDEMIC; FEMALE; GREECE; HIGH RISK BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; HUMAN; MALE; MIDDLE AGED; PREVALENCE; PSYCHOTHERAPY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COMORBIDITY; DISEASE OUTBREAKS; FEMALE; GREECE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; RISK-TAKING; SOCIOENVIRONMENTAL THERAPY; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84938153667     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12999     Document Type: Article

References (53)

1. Nikolopoulos G., Paraskevis D., Hatzakis A. HIV epidemiology in Greece. Future Microbiol 2008; 3: 507-16.
2. Hellenic Center for Disease Control and Prevention. HIV/AIDS Surveillance Report in Greece, 31-12-2011, (Issue 26). Athens 2011. Available at: http://www.keelpno.gr
3. Paraskevis D., Nikolopoulos G., Tsiara C., Paraskeva D., Antoniadou A., Lazanas M., et al. HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report. Euro Surveill 2011; 16: pii=19962.
4. Paraskevis D., Nikolopoulos G., Fotiou A., Tsiara C., Paraskeva D., Sypsa V., et al. Economic recession and emergence of an HIV-1 outbreak among drug injectors in Athens metropolitan area: a longitudinal study. PLOS ONE 2013; 8: e78941.
5. Greek Reitox Focal Point. Annual report, 2011. Available at: http://www.ektepn.gr/.
6. Malliori M., Golna C., Souliotis K., Hatzakis A. Managing opioid dependence treatment and controlling for HIV incidence among injecting drug users in Greece: a case study of optimism in the face of adversity. Addiction 2013; 108: 1174-5.
7. World Health Organization (WHO), United Nations Office on Drugs and Crime (UNODC) and Joint United Nations Programme on HIV and AIDS (UNAIDS) Technical Guide for Countries to Set Targets for Universal Access to HIV Prevention, Treatment and Care for Injecting Drug Users. Geneva: World Health Organization; 2009.
8. Sypsa V., Paraskevis D., Malliori M., Nikolopoulos G. K., Panopoulos A., Kantzanou M., et al. Homelessness and other risk factors for HIV infection in the current outbreak among injection drug users in Athens, Greece. Am J Public Health 2015; 105: 196-204.
9. National Institute on Drug Abuse (NIDA) and International AIDS Society (IAS) Report Prevention and Treatment of HIV/AIDS Among Drug Using Populations: A Global Perspective. Washington, DC: NIDA/IAS; 2010.
10. Heckathorn D. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl 1997; 44: 1741-99.
11. Malekinejad M., Johnston L. G., Kendall C., Kerr L. R., Rifkin M. R., Rutherford G. W. Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: a systematic review. AIDS Behav 2008; 12: S105-30.
12. Heckathorn D. D., Semaan S., Broadhead R. S., Hughes J. Extensions of respondent-driven sampling: a new approach to the study of injection drug users aged 18-25. AIDS Behav 2002; 6: 55-67.
13. Johnston L. G., Sabin K. Sampling hard-to-reach populations with respondent driven sampling. Methodol Innov Online 2010; 5: 38-48.
14. Gallagher K. M., Sullivan P. S., Lansky A., Onorato I. M. Behavioral surveillance among people at risk for HIV infection in the U.S.: the National HIV Behavioral Surveillance System. Public Health Rep 2007; 122: 32-8.
15. Wiessing L., Bravo M. J., European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) DRID Guidance Module: Behavioural Indicators for People Who Inject Drugs. Lisbon: EMCDDA; 2013.
16. Salganik M. J. Variance estimation, design effects, and sample size calculations for respondent-driven sampling. J Urban Health 2006; 83: i98-112.
17. StataCorp Stata Statistical Software: Release 11. College Station, TX: StataCorp; 2009.
18. Heckathorn D. D. Extensions of respondent-driven sampling: analyzing continuous variables and controlling for differential recruitment. Sociol Methodol 2007; 37: 151-207.
19. Volz E., Wejnert C., Cameron C., Spiller M., Barash V., Degani I., et al. Respondent-Driven Sampling Analysis Tool (RDSAT), version 7.1. Ithaca, NY: Cornell University; 2012.
20. Eritsyan K., Heimer R., Barbour R., Odinokova V., White E., Rusakova M. M., et al. Individual-level, network-level and city-level factors associated with HIV prevalence among people who inject drugs in eight Russian cities: a cross-sectional study. BMJ Open 2013; 3: pii: e002645.
21. Yen Y. F., Rodwell T. C., Yen M. Y., Hsu Y. H., Chuang P., Li L. H., et al. HIV infection risk among injection drug users in a methadone maintenance treatment program, Taipei, Taiwan 2007-2010. Am J Drug Alcohol Abuse 2012; 38: 544-50.
22. Uuskula A., McMahon J. M., Kals M., Talu A., Abel-Ollo K., Ruutel K., et al. Risk for heterosexual HIV transmission among non-injecting female partners of injection drug users in Estonia. AIDS Behav 2013; 17: 879-88.
23. Estebanez P. E., Russell N. K., Aguilar M. D., Beland F., Zunzunegui M. V. Women, drugs and HIV/AIDS: results of a multicentre European study. Int J Epidemiol 2000; 29: 734-43.
24. Lansky A., Drake A., Wejnert C., Pham H., Cribbin M., Heckathorn D. D. Assessing the assumptions of respondent-driven sampling in the national HIV Behavioral Surveillance System among injecting drug users. Open AIDS J 2012; 6: 77-82.
25. Wang K., Fu H., Longfield K., Modi S., Mundy G., Firestone R. Do community-based strategies reduce HIV risk among people who inject drugs in China? A quasi-experimental study in Yunnan and Guangxi provinces. Harm Reduct J 2014; 11: 15.
26. Rahnama R., Mohraz M., Mirzazadeh A., Rutherford G., McFarland W., Akbari G., et al. Access to harm reduction programs among persons who inject drugs: findings from a respondent-driven sampling survey in Tehran, Iran. Int J Drug Policy 2014; 25: 717-23.
27. Morineau G., Bollen L. J., Syafitri R. I., Nurjannah N., Mustikawati D. E., Magnani R. HIV prevalence and risk behaviours among injecting drug users in six Indonesian cities: implications for future HIV prevention programs. Harm Reduct J 2012; 9: 37.
28. Greek REITOX Focal Point The 2012 National Report to the EMCDDA (2011 data). Athens: Greek REITOX Focal Point; University Mental Health Research Institute; 2012.
29. Heckathorn D. Respondent-driven sampling II: deriving valid population estimates from chain referral samples of hidden populations. Soc Probl 2002; 49: 11-34.
30. Friedman S. R., Friedmann P., Telles P., Bastos F., Bueno R., Mesquita F., et al. New injectors and HIV-1 risk. In: Stimson G. V., Des Jarlais D. C., Ball A. L., editors. Drug Injecting and HIV Infection: Global Dimensions and Local Responses. London: UCL Press; 1998: 76-90.
31. Fotiou A., Giannou F., Lagakos L. HIV outbreak in IDUs in Greece. Update on Situation and Responses (2nd Meeting on Detecting and Responding to Outbreaks of HIV Among People who Inject Drugs). Lisbon, Portugal: EMCCDA; 2012.
32. Raoult D., Foucault C., Brouqui P. Infections in the homeless. Lancet Infect Dis 2001; 1: 77-84.
33. Coady M. H., Latka M. H., Thiede H., Golub E. T., Ouellet L., Hudson S. M., et al. Housing status and associated differences in HIV risk behaviors among young injection drug users (IDUs). AIDS Behav 2007; 11: 854-63.
34. Strathdee S. A., Patrick D. M., Currie S. L., Cornelisse P. G., Rekart M. L., Montaner J. S., et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. Aids 1997; 11: F59-65.
35. Estebanez P., Russell N. K., Aguilar M. D., Cifuentes I., Zunzunegui M. V., McPherson K. Determinants of HIV prevalence amongst female IDU in Madrid. Eur J Epidemiol 2001; 17: 573-80.
36. Donoghoe M. C., Dolan K. A., Stimson G. V. Life-style factors and social circumstances of syringe sharing in injecting drug users. Br J Addict 1992; 87: 993-1003.
37. Linton S. L., Celentano D. D., Kirk G. D., Mehta S. H. The longitudinal association between homelessness, injection drug use, and injection-related risk behavior among persons with a history of injection drug use in Baltimore, MD. Drug Alcohol Depend 2013; 132: 457-65.
38. Metraux S., Metzger D. S., Culhane D. P. Homelessness and HIV risk behaviors among injection drug users. J Urban Health 2004; 81: 618-29.
39. Friedman S. R., Neaigus A., Jose B., Curtis R., Goldstein M., Ildefonso G., et al. Sociometric risk networks and risk for HIV infection. Am J Public Health 1997; 87: 1289-96.
40. Kottiri B. J., Friedman S. R., Neaigus A., Curtis R., Des Jarlais D. C. Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. J Acquir Immune Defic Syndr 2002; 30: 95-104.
41. Corsi K. F., Dvoryak S., Garver-Apgar C., Davis J. M., Brewster J. T., Lisovska O., et al. Gender differences between predictors of HIV status among PWID in Ukraine. Drug Alcohol Depend 2014; 138: 103-8.
42. Barrio G., Bravo M. J., Brugal M. T., Diez M., Regidor E., Belza M. J., et al. Harm reduction interventions for drug injectors or heroin users in Spain: expanding coverage as the storm abates. Addiction 2012; 107: 1111-22.
43. Desenclos J. C., Papaevangelou G., Ancelle-Park R. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users. The European Community Study Group on HIV in Injecting Drug Users. Aids 1993; 7: 1371-7.
44. Stimson G. V. Has the United Kingdom averted an epidemic of HIV-1 infection among drug injectors? Addiction 1996; 91: 1085-8; discussion 1089-99.
45. Uuskula A., Kalikova A., Zilmer K., Tammai L., DeHovitz J. The role of injection drug use in the emergence of human immunodeficiency virus infection in Estonia. Int J Infect Dis 2002; 6: 23-7.
46. Rhodes T., Lowndes C., Judd A., Mikhailova L. A., Sarang A., Rylkov A., et al. Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia. Aids 2002; 16: F25-31.
47. Shaboltas A. V., Toussova O. V., Hoffman I. F., Heimer R., Verevochkin S. V., Ryder R. W., et al. HIV prevalence, sociodemographic, and behavioral correlates and recruitment methods among injection drug users in St. Petersburg, Russia. J Acquir Immune Defic Syndr 2006; 41: 657-63.
48. Platt L., Bobrova N., Rhodes T., Uuskula A., Parry J. V., Ruutel K., et al. High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment. Aids 2006; 20: 2120-3.
49. Pharris A., Wiessing L., Sfetcu O., Hedrich D., Botescu A., Fotiou A., et al. Human immunodeficiency virus in injecting drug users in Europe following a reported increase of cases in Greece and Romania, 2011. Euro Surveill 2011; 16: pii: 20032.
50. Hedrich D., Kalamara E., Sfetcu O., Pharris A., Noor A., Wiessing L., et al. Human immunodeficiency virus among people who inject drugs: is risk increasing in Europe? Euro Surveill 2013; 18: 20648.
51. Mills H. L., White E., Colijn C., Vickerman P., Heimer R. HIV transmission from drug injectors to partners who do not inject, and beyond: modelling the potential for a generalized heterosexual epidemic in St. Petersburg, Russia. Drug Alcohol Depend 2013; 133: 242-7.
52. Friedman S. R., West B. S., Tempalski B., Morton C. M., Cleland C. M., Des Jarlais D. C., et al. Do metropolitan HIV epidemic histories and programs for people who inject drugs and men who have sex with men predict AIDS incidence and mortality among heterosexuals? Ann Epidemiol 2014; 24: 304-11.
53. Donoghoe M. C., Stimson G. V., Dolan K. A. Sexual behaviour of injecting drug users and associated risks of HIV infection for non-injecting sexual partners. AIDS Care 1989; 1: 51-8.